Browse Title Index

Issue Title File
Vol 25, No 1 (2023) Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review PDF
(Rus)
Kolyadina I.V.
Vol 25, No 1 (2023) Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review PDF
(Rus)
Kolyadina I.V.
Vol 24, No 4 (2022) Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review PDF
(Rus)
Ognerubov N.A.
Vol 14, No 4 (2012) Fotodinamicheskaya terapiya pri kombinirovannom lechenii bol'nykh melanomoy kozhi
Mogilevskiy I.L., Polsachev V.I., Slovokhodov E.K., Magomedov M.R., Karlova M.A.
Vol 6, No 4 (2004) Fragmin v onkologii
Ptushkin V.V.
Vol 8, No 1 (2006) Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom
Makarov O.G.
Vol 10, No 1 (2008) Fraksiparin v profilaktike tromboticheskikh oslozhneniy u onkoginekologicheskikh bol'nykh
Somonova O.V., Madzhuga A.V., Elizarova A.L., Zubrikhina G.N., Kuznetsov V.V.
Vol 24, No 1 (2022) From the editor-in-chief of the journal "Modern Oncology" Academician of the Russian Academy of Sciences I.V. Poddubnaya PDF
(Rus)
Poddubnaya I.V.
Vol 3, No 4 (2001) Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka
Manzyuk L.V., Perevodchikova N.I., Gorbunova V.A., Artamonova E.V., Rotobel'skaya L.E., Abramova N.A.
Vol 9, No 1 (2007) Ftorafur®. Perspektivy primeneniya v sovremennoy klinicheskoy onkologii
Gutorov S.L.
Vol 14, No 3 (2012) Fulvestrant - endokrinnaya terapiya rasshirennogo spektra deystviya
Meshcheryakov A.A.
Vol 14, No 4 (2012) Fulvestrant (Fazlodeks)v dozirovke 500 mg uvelichivaet medianuobshchey vyzhivaemosti na 4,1 mes po sravneniyus dozirovkoy 250 mg
- -.
Vol 18, No 4 (2016) Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
Vladimirova L.Y.
Vol 9, No 3 (2007) Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
Komarova V.P., Komarova L.E., Poddubnaya I.V.
Vol 12, No 4 (2010) Fulvestrant vne klinicheskikhissledovaniy (opyt otdeleniya khimioterapii)
Voznyy, E.K., Grishunenkova, E.P., Astrakhankina, T.A., Popov, A.Y., Galkin M.M.
Vol 23, No 4 (2021) Gastric cancer: Russian clinical guidelines PDF
(Rus)
Besova N.S., Kalinin A.E., Nered S.N., Triakin A.A., Gamaiunov S.V., Kozlov N.A., Stilidi I.S., Karachun A.M., Kononets P.V., Malikhova O.A., Riabov A.B., Khomiakov V.M., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Nevol'skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil'mutdinova I.R., Eremushkin M.A., Ivanova G.E., Kondrat'eva K.O., Konchugova T.V., Krutov A.A., Obukhova O.A., Semiglazova T.I., Filonenko E.V., Khulamkhanova M.M., Romanov A.I.
Vol 17, No 2 (2015) Gastrointestinal stromal tumors: The 2015 asco News
Arkhiri P.P.
Vol 12, No 3 (2010) Gastrointestinal'nye stromal'nyeopukholi: obzor materialov ASCO 2010
Nikulin M.P., Stilidi I.S.
Vol 15, No 3 (2013) Gefitinib – terapiya vybora 1-y linii nemelkokletochnogo raka legkogo u bol'nykh s nalichiem mutatsiy v gene EGFR
Bolotina L.V.
Vol 4, No 1 (2002) Geksalen v novykh kombinatsiyakh s gemzarom ili vepezidom pri platino-taksano-rezistentnykh formakh raka yaichnikov
Gorbunova V.A., Blyumenberg A.G.
Vol 3, No 2 (2001) Gemzar (gemtsitabin) v lechenii nemelkokletochnogo raka legkogo
Bychkov M.B., Voznyy E.K., Gorbunova V.A., Marenich A.F.
Vol 6, No 1 (2004) Gemzar v kombinatsii s tsisplatinom v terapii infil'trativnykh form raka mochevogo puzyrya
Arzumanov A.A., Shkol'nik M.I., Leonenko R.V., Maslyukova E.A., Maslyukova A., Karelin M.I.
Vol 22, No 4 (2020) Gene polymorphisms role of blood coagulation in myocardial infarction development in patients with malignant tumors of thoracoabdominal localization PDF
(Rus)
Korolyova A.A., Gerasimov S.S., Kononets P.V., Lyubchenko L.N.
Vol 24, No 3 (2022) Genetic markers associated with resistance to radioiodine therapy in thyroid cancer patients: Prospective cohort study PDF
(Rus)
Denisenko N.P., Shuev G.N., Mukhamadiev R.H., Perfilieva O.M., Kazakov R.E., Kachanova A.A., Milyutina O.I., Konenkova O.V., Ryzhkin S.A., Ivashchenko D.V., Bure I.V., Kirienko S.L., Zhmaeva E.M., Mirzaev K.B., Ametov A.S., Poddubnaya I.V., Sychev D.A.
Vol 3, No 4 (2001) Genetika raka zheludochno-kishechnogo trakta
Gar'kavtseva R.F., Kazubskaya T.P., Belev N.F., Sel'chuk V.Y.
Vol 25, No 4 (2023) Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review PDF
(Rus)
Timoshkina N.N., Petrusenko N.A., Gabrichidze P.N., Cherkess M.A., Pushkareva T.F., Savchenko D.A.
Vol 10, No 2 (2008) Germinogennye opukholi u bol'nykh SPIDom
Pivnik A.V., Seregin N.V., Parkhomenko Y.G., Tishkevich O.A., Kovrigina A.M., Gruzdev B.M., Petrova E.V., Likunov E.B.
Vol 11, No 3 (2009) Gertseptin: mekhanizm deystviya
Imyanitov E.N.
Vol 5, No 3 (2003) Gistologicheskie i gistoimmunokhimicheskie osobennosti uveal'noy melanomy pri pervichno-mnozhestvennom porazhenii i solitarnoy uveal'noy melanome
Poddubnaya I.V., Grishina E.E., Lerner M.Y., Nechestnyuk S.Y.
Vol 4, No 1 (2002) Glivek - patogeneticheskaya terapiya zlokachestvennykh novoobrazovaniy
Meshcheryakov A.A.
Vol 11, No 4 (2009) Glivek v ad\"yuvantnoy terapii gastro-intestinal'nykh stromal'nykh opukholey. Novoe pokazanie – novye vozmozhnosti
- -.
Vol 10, No 4 (2008) Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey
Rasner P.I., Pushkar' D.Y., Govorov A.V.
Vol 2, No 3 (2000) Gormonoterapiya generalizovannogo raka predstatel'noy zhelezy
Rusakov I.G., Alekseev B.Y.
Vol 25, No 1 (2023) Guidelines for the endoscopic diagnosis, treatment and follow-up of patients with epithelial neoplasms of the colon. 2022 PDF
(Rus)
Malikhova O.A., Zavyalov D.V., Kashin S.V., Shishin K.V., Ilyashenko M.G., Kireev S.U., Mikhin A.I., Sidorova A.N., Malikhov A.G.
Vol 22, No 1 (2020) Hairy cell leukemia. Clinical recommendations PDF
(Rus)
Al’-Radi L.S., Baikov V.V., Kovrigina A.M., Krivolapov I.A., Moiseeva T.N., Nikitin E.A., Pivnik A.V., Stadnik E.A., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Vol 19, No 4 (2017) Head and neck cutaneous melanoma: an influence of surgical resection margin on long-term results PDF
(Rus)
Pak M.B., Mudunov A.M., Demidov L.V., Azizyan R.I., Brzhezovskiy V.Z., Stelmah D.K., Alymov Y.V., Ignatova A.V.
Vol 16, No 3 (2014) HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Besova N.S.
Vol 11, No 2 (2009) HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy
Ognerubova I.N.
Vol 14, No 1 (2012) HER2-testirovanie metodamiimmunogistokhimii, fluorestsentnoy(FISH) i khromogennoy (SISH) in situgibridizatsii pri rake zheludkai pishchevodno-zheludochnogo perekhoda
Zavalishina L.E., Ryazantseva A.A., Andreeva Y.Y., Frank G.A.
Vol 17, No 3 (2015) Hereditary ovarian cancer
Demidova I.A.
Vol 25, No 2 (2023) Heterogeneous diffuse large B-cell lymphoma: accurate diagnosis as a key to successful therapy. A review PDF
(Rus)
Babicheva L.G., Poddubnaya I.V.
Vol 16, No 2 (2014) High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)
Seryakov A.P., Ovchinnikova L.K., Zabelin M.V., Yakubov T.Z., Sidorov D.B., Ovchinnikov M.V.
Vol 22, No 2 (2020) High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience PDF
(Rus)
Mochkin N.E., Sarzhevskiy V.O., Dubinina J.N., Smirnova E.G., Fedorenko D.A., Bannikova A.E., Kolesnikova D.S., Bogatyrev V.S., Samoylova A.A., Faddeev N.M., Melnichenko V.Y.
Vol 16, No 1 (2014) High-dose chemotherapy with hematopoietic stem cell rescuein children older than 3 year with medulloblastoma: results of single institution trial
Babelyan S.S., Subbotina N.N., Dolgopolov I.S., Gorelyshev S.K., Mentkevich G.L., Byarshinov V.K., Pimenov R.I.
Vol 23, No 1 (2021) Hodgkin lymphoma. ASCO, EHA and ASH 2020 news PDF
(Rus)
Demina E.A.
Vol 22, No 2 (2020) Hodgkin's lymphoma PDF
(Rus)
Demina E.A., Tumyan G.S., Moiseeva T.N., Mikhailova N.B., Myakova N.V., Rumyantsev A.G., Maschan A.A., Kaplanov K.D., Shmakov R.G., Falaleeva N.A., Ptushkin V.V., Osmanov E.A., Poddubnaya I.V., Baikov V.V., Kovrigina A.M., Konovalov D.M., Trofimova O.P., Sotnikov V.M., Ilin N.V., Vinogradova Y.N., Nechesnyuk A.V., Parkhomenko R.A., Stefanov D.N., Nevolsky A.A., Ivanov S.A., Khaylova Z.V.
Vol 25, No 4 (2023) How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review PDF
(Rus)
Zhukova L.G., Bordin D.S., Dubtsova E.A., Ilin M.A., Kiriukova M.A., Feoktistova P.S., Egorov V.I.
Vol 21, No 1 (2019) HPV-associated lesions in the Russian Federation: assessment of the problem PDF
(Rus)
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I.
Vol 25, No 2 (2023) Hydroxyethyldimethyldihydropyrimidine as the drug of choice for the prevention of paraprosthetic seromas in breast reconstructive surgery: A retrospective study PDF
(Rus)
Khodyrev S.A., Shabaev R.M., Kolyadina I.V., Starokon P.M., Levchuk A.L., Samoylenko V.M.
Vol 25, No 4 (2023) Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] PDF
(Rus)
Yudina E.V.
Vol 19, No 2 (2017) Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal PDF
(Rus)
Glebovskaya V.V., Tkachev S.I., Ivanov S.M., Nazarenko A.V., Rasulov A.O., Gordeev S.S., Bulychkin P.V., Besova N.S., Barsukov U.A., Trofimova O.P., Borisova T.N., Timoshkina E.V.
Vol 22, No 4 (2020) Ifosfamide/cyclofosfamide-induced methemoglobinemia in pediatric patients with hemoblastoses PDF
(Rus)
Valiev T.T., Korkina Y.S.
Vol 23, No 2 (2021) Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review PDF
(Rus)
Lyadova M.A., Lyadov V.K.
Vol 9, No 1 (2007) Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera)
Shisterova O.A., Golik E.P.
Vol 2, No 4 (2000) Immunoglobulinsekretiruyushchaya limfoma iz kletok marginal'noy zony selezenki (kliniko-immunomorfologicheskaya kharakteristika)
Gorodetskiy V.R., Probatova N.A., Tupitsyn N.N., Varlamova E.Y., Kondrat'eva T.T., Balakireva T.V., Sholokhova E.N., Saridi E.Y.
Vol 3, No 2 (2001) Immunoliposomy - novoe sredstvo dostavki lekarstvennykh preparatov
Baryshnikov A.Y., Oborotova N.A.
Vol 25, No 1 (2023) Immunological detection of bone marrow lesions in skin melanoma and its clinical significance: Observational study PDF
(Rus)
Krylovetskaya M.A., Chulkova S.V., Markina I.G., Chernysheva O.A., Komarov I.G., Kolbatskaya O.P., Kupryshina N.A., Logachev A.V., Mikhaylova I.N., Demidov L.V., Tupitsyn N.N.
Vol 17, No 1 (2015) Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Frank G.A., Komov D.V., Karseladze A.I., Bastiaannet E., Dekker-Ensink N.G.
Vol 8, No 1 (2006) Immuno-morfologicheskie faktory prognoza pri limfome Khodzhkina
Tumyan G.S., Tupitsyn N.N., Probatova N.A., Kovrigina A.M., Sholokhova E.N.
Vol 24, No 1 (2022) Immuno-morphological characteristics of bone marrow in patients with ovarian cancer PDF
(Rus)
Kozhonalieva A.M., Chulkova S.V., Stilidi I.S., Artamonova E.V., Poddubnaya I.V., Kolbatskaya O.P., Kupryshina N.A., Egorova A.V., Tupitsyn N.N.
Vol 14, No 4 (2012) Immunoterapiya dendritnymi kletkami v klinicheskoy onkologii*
Shevtsov M.A., Khachatryan V.A., Galibin O.V., Margulis B.A.
Vol 21, No 3 (2019) Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population PDF
(Rus)
Grechukhina K.S., Zhukova L.G.
Vol 18, No 2 (2016) Improved technique thyroidectomy with lateral modified radical neck dissection PDF
(Rus)
Shabunin A.V., Dolidze D.D., Podvyaznikov S.O., Melnik K.V., Mumladze R.B., Vardanyan A.V., Lebedinskiy I.N., Grachev P.V.
Vol 22, No 4 (2020) Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor PDF
(Rus)
Ganshina I.P., Ivanova K.A., Lubennikova E.V., Arkhipov A.V., Zhukova L.G.
Vol 25, No 1 (2023) Improving outcomes for people with a primary malignant brain tumour and their carers through early palliative interventions PDF
(Rus)
Ivanchenko K.A.
Vol 5, No 3 (2003) Infektsii zheludochno - kishechnogo trakta u onkologicheskikh bol'nykh: sovremennye podkhody k lecheniyu
Shevola D., Dmitrieva N.V., Petukhova I.N., Varlan G.V., Averina N.A., Volkova Z.V., Petrukhina N.N., Korotkov A.M.
Vol 23, No 3 (2021) Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer PDF
(Rus)
Brish N.A., Semiglazova T.Y., Karachun A.M., Shevkunov L.N., Ulyanchenko Y.A., Artemyeva A.S., Golovanova T.S., Tkachenko E.V., Alexeeva Y.V., Sharashenidze S.M., Strakh L.V., Protsenko S.A., Teletaeva G.M., Filatova L.V., Kasparov B.S., Semiglazov V.V., Belyaev A.M.
Vol 25, No 1 (2023) Influence of radiation therapy on the development of complications in single-stage autologous breast reconstruction with a DIEP-flap in breast cancer patients: a retrospective study PDF
(Rus)
Duadze I.S., Kaprin A.D., Zikiryakhodzhaev A.D., Reshetov I.V., Usov F.N., Rasskazova E.A., Sukhotko A.S., Starkova M.V., Bagdasarova D.V., Dzhabrailova D.S., Khakimova S.G.
Vol 23, No 4 (2021) Influence of retroelements on oncogenes and tumor suppressors in carcinogenesis: A review PDF
(Rus)
Mustafin R.N.
Vol 12, No 4 (2010) Informatsionnoe soobshchenie o XXIVsemirnom protivorakovom kongresse
Kachanov D.Y.
Vol 6, No 3 (2004) Informatsiya o nachale provedeniya mezhdunarodnogo issledovaniya metoda lecheniya bol'nykh s follikulyarnoy nekhodzhkinskoy CD20+ V-kletochnoy limfomoy
- -.
Vol 5, No 2 (2003) Ingibin A, estradiol, FSG i SA-125 v diagnostike i monitoringe granulezokletochnoy opukholi yaichnikov
Kerzhkovskaya N.S., Lyubimova N.V., Zhordania K.I., Bogatyrev V.N., Rotobel'skaya L.E., Anurova O.A., Barinov V.V.
Vol 3, No 2 (2001) Ingibitor signal'nykh putey STI 571 (Signal Transductor Inhibitor) - novoe napravlenie v lechenii khronicheskogo mieloleykoza
Turkina A.G.
Vol 12, No 4 (2010) Ingibitory angiogeneza v terapiiepitelial'nogo raka yaichnikov
Tyulyandin S.A., Tyulyandina A.S.
Vol 14, No 4 (2012) Ingibitory tirozinkinazy EGFR v terapii 1-y linii nemelkokletochnogo raka legkogo: perekhod ot empiricheskogo podkhoda k personalizatsii lecheniya
Artamonova E.V.
Vol 12, No 3 (2010) Ingibitory tirozinkinazy retseptoraepidermal'nogo faktora rosta:pokhozhie, no raznye? (Referat)
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
Vol 9, No 3 (2007) Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii
Konstantinova M.M.
Vol 22, No 2 (2020) Inhibin B in diagnosis and monitoring of granulosa-cell tumors of ovary PDF
(Rus)
Lyubimova N.V., Beishembaev A.M., Timofeev Y.S., Zhordania K.I., Kushlinskii N.E.
Vol 25, No 3 (2023) Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] PDF
(Rus)
Melnikov V.D.
Vol 23, No 4 (2021) Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021 PDF
(Rus)
Editorial B.
Vol 24, No 2 (2022) Innovations in the therapy of oncohematological diseases PDF
(Rus)
Editorial B.
Vol 18, No 1 (2016) Insulin-like growth factors in patients with ovarian tumors (results of own research) PDF
(Rus)
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
Vol 19, No 2 (2017) Interferon α (IFN-α) vs. the combination IFN-α and octreotide LAR in the treatment of patients with well differentiated neuroendocrine tumors (NET) of various localizations PDF
(Rus)
Yemelyanova G.S., Kuzminov A.E., Orel N.F., Markovich A.A., Kuznetsova A.A., Gorbunova V.A.
Vol 22, No 4 (2020) Interim results of a multicenter retrospective-prospective observational post-marketing study of Extimia® BIOCAD (INN: empegfilgrastim) to evaluate safety and efficacy in patients with lymphoproliferative diseases receiving cytotoxic therapy PDF
(Rus)
Nesterova E.S., Klitochenko T.Y., Glonina N.N., Fadeeva N.V., Sannikova T.A., Lyalina I.S., Shelekhova T.V., Sherstnev D.G., Voloshin S.V., Sarzhevskii V.O., Hofman A.A., Ichshanov D.G., Poddubnaya I.V.
Vol 19, No 2 (2017) Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary? PDF
(Rus)
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
Vol 25, No 3 (2023) International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review) PDF
(Rus)
Levashov A.S., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V.A., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadyrov S.U., Polyakov V.G.
Vol 14, No 3 (2012) Internet-konferentsiya «Follikulyarnye limfomy»
- -.
Vol 25, No 2 (2023) Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study PDF
(Rus)
Chulkova S.V., Sholokhova E.N., Poddubnaya I.V., Stilidi I.S., Burov D.A., Tupitsyn N.N.
Vol 17, No 2 (2015) Intrahepatic cholangiocellular carcinoma (review)
Zharikov Y.O., Shevchenko T.V., Zhao A.V.
Vol 3, No 2 (2001) Invazivnye mikozy v onkogematologii: sovremennoe sostoyanie problemy
Klyasova G.A.
Vol 19, No 3 (2017) Irreversible electroporation of locally advanced unresectable pancreatic cancer PDF
(Rus)
Patyutko Y.I., Polyakov A.N., Kudashkin N.E., Podluzhnyi D.V., Chistyakova O.V.
Vol 23, No 2 (2021) Isatuximab, a novel anti-CD38 monoclonal antibody in the treatment of multiple myeloma: efficacy and safety PDF
(Rus)
Zatolochina K.E., Zyryanov S.K., Ushkalova E.A.
Vol 23, No 1 (2021) Isolated splenic metastases from colon cancer: clinical observations PDF
(Rus)
Ognerubov N.A., Antipova T.S., Ognerubova M.A.
Vol 10, No 3 (2008) Ispol'zovanie generikov v onkologii: est' li problemy?
Zyryanov S.K., Belousov Y.B.
Vol 9, No 2 (2007) Ispol'zovanie komp'yuternoy obrabotki dannykh videoendoskopicheskogo issledovaniya gortani v planirovanii i otsenke rezul'tatov lecheniya raka gortani
Shinkarev S.A., Korenev A.A., Podol'skiy V.N., Bobrovskiy A.V., Shinkareva E.V.
Vol 4, No 4 (2002) Ispol'zovanie metoda AKS dlya kolichestvennoy otsenki "otveta na lechenie" onkologicheskikh bol'nykh
Teplyakov V.V., Lebedenko I.M., Kovalevskiy E.E.
Vol 14, No 3 (2012) Ispol'zovanie pokazatelya effektivnosti zatrat pri kompleksnoy farmakoekonomicheskoy otsenke dorogostoyashchikh meditsinskikh tekhnologiy. Primer bevatsizumaba
Ryazhenov V.V., Gorokhova S.G.
Vol 4, No 3 (2002) Ispol'zovanie rekonstruktivnykh plasticheskikh operatsiy v lechenii opukholey golovy i shei
Azizyan R.I., Podvyaznikov S.O., Fedotenko S.P., Taneeva A.S., Matakova I.S.
Vol 9, No 2 (2007) Issledovanie III fazy pokazalo, chto primenenie Neksavara® na 44% uvelichivaet obshchuyu vyzhivaemost' u bol'nykh rakom pecheni 4 iyunya 2007 g., Berlin
- -.
Vol 14, No 2 (2012) Issledovanie III fazy: znachitel'noe uvelichenie prodolzhitel'nosti zhizni u patsientov s naibolee rasprostranennym tipom nemelkokletochnogo raka legkogo, poluchavshikh prodolzhennuyu podderzhivayushchuyu terapiyu na osnove preparata Alimta
- -.
301 - 400 of 1301 Items << < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies